MTOR and gastric cancer: To further identify the effect of SB365 on c-Met/Akt/mTOR pathway, researchers found SB365 treatment can reduce the levels of p-c-Met, p-Akt, p-mTOR and p-p70S6K in MKN-45 gastric cancer cells [34].